Dr. Cumbermack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
138 Leader Ave
University of Kentucky, Pediatric Cardiology
Lexington, KY 40508Phone+1 859-323-1432Fax+1 859-323-3499
Summary
- Medical Director of Congenital Echocardiography Laboratory
Associate Division Chief, Pediatric Cardiology
Education & Training
- Emory University School of MedicineFellowship, Pediatric Cardiology, 2009 - 2010
- Emory University School of MedicineFellowship, Pediatric Cardiology, 2006 - 2009
- University of California Davis HealthResidency, Pediatrics, 2003 - 2006
- University of Vermont College of MedicineClass of 2003
- Stanford UniversityBAS, Biological Sciences and Economics, 1993 - 1997
Certifications & Licensure
- KY State Medical License 2011 - 2025
- OH State Medical License 2017 - 2025
- GA State Medical License 2007 - 2011
- CA State Medical License 2004 - 2009
- American Board of Pediatrics Pediatric Cardiology
Clinical Trials
- Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) Start of enrollment: 2020 Aug 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 12 citationsProspective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.Jill P Buyon, Mala Masson, Caroline G Izmirly, Colin Phoon, Ruben Acherman
Arthritis & Rheumatology. 2024-03-01 - 4 citationsKnowledge is power: regarding SMFM Consult Series #64: Systemic lupus erythematosus in pregnancy.Bettina F Cuneo, Jill P Buyon, Lisa Sammaritano, Edgar Jaeggi, Bhawna Arya
American Journal of Obstetrics and Gynecology. 2023-10-01 - 14 citationsEffect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).Lindsay R. Freud, Louise Wilkins-Haug, Rebecca S. Beroukhim, Terra Lafranchi, Colin K L Phoon
The American Journal of Cardiology. 2021-02-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: